ARTV Competitors & Alternatives
Compare Artiva Biotherapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ARTV
Main Stock$10.68
Tradestie Score
55
Market Cap
$71.32M
Revenue Growth
-1.0%
Analyst Upside
+192.1%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.78
|
$552.46M | - | 50 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.66
|
$540.97M | - | 51 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.86
|
$533.99M | - | 56 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.66
|
$529.35M | 5.5 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.33
|
$512.39M | - | 58 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$31.92
|
$505.12M | 1.7 | 61 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$116.16
|
$492.21M | - | 50 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$42.00
|
$474.20M | 26.6 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$5.54
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.68
|
$463.20M | - | 56 | Compare |
More ARTV Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry